Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Gadoquatrane in Renal Impairment
NCT05061979Phase 1Completed
- Sponsor
- Bayer
- Start
- Oct 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of gadoquatrane (3 arms), sponsored by Bayer. Primary endpoints: Area under the concentration versus time curve from zero to infinity, Maximum observed drug concentration and 1 more. Started Oct 2021; status: completed.
02
Drugs
gadoquatrane
Beyond the preview
Go deeper on NCT05061979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05061979.